Shin-Nippon

Shin-Nippon: nasal drug delivery

Translational Research (TR) Company, a division of Shin Nippon Biomedical Laboratories, Ltd (SNBL), has developed an exclusive technology for nasal drug delivery, the μco™ system (“myu-co” system). This system comprises two technological elements: powder carrier technology and delivery device technology. In addition to licensing this platform technology and internally developed products to pharmaceutical companies, SNBL supports the research and development of pharmaceutical products. They leverage the Group's extensive experience and capabilities in drug development as a Contract Research Organization (CRO), and utilize their world-renowned state-of-the-art preclinical and clinical study facilities.